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1. Introduction
In a recent survey on forecasting with panel data, Baltagi (2008) contrasts the rich and 
extensive forecasting literature using time series data with the relatively modest literature on 
forecasting using panel data. Even within the area of panel forecasting, there is very little general 
research on micro panels where N, the number of individuals, is large relative to T, the number of 
time series observations. Baltagi (2008) references only one relevant paper by Baillie and Baltagi 
(1999) who consider forecasting in the context of the standard one-way error component model and 
compare a number of predictors including models estimated by Ordinary Least Squares (OLS) and 
fixed effects (FE) as well as variants of the best linear unbiased predictor (BLUP) assuming a random 
effects specification. Given the relatively good performance of the fixed effects predictor (FEP), even 
when the random effects specification is the true generating process and hence when the FEP is not 
optimal, Baillie and Baltagi (1999) argue that there is a clear preference for the FEP in order to guard 
against possible omitted variable biases associated with correlations between unobservable 
individual specific effects and covariates included in the models. This argument, however, is made 
without supporting evidence in the case of correlated individual effects but the preference for a FE 
approach does mirror the conventional wisdom when parameter estimation, rather than 
forecasting, is the main objective.  
Our primary aim is to provide further comparisons of alternative predictors in the context of 
the motivating example of risk prediction in health economics. Broadly defined, risk adjustment in 
health means the use of patient-level information to explain variation in health care utilization, costs 
and health outcomes (Ellis, 2008). The application of risk adjustment is typically for payment 
purposes, such as payment to competitive health insurance plans or to health providers, and health 
insurance premium setting. A good risk adjustment prediction model is one that can forecast 
accurately the resource use of the individual. In particular, we ask whether the superiority of 
alternative predictors based on a model estimated by FE over one estimated by OLS is in fact 
replicated when individual effects are correlated with regressors and in the context of micro panels 
such as the data we use. The key feature of such panels is the availability of a very large number of 
individuals (more than 250,000 in our data) but only for a limited time dimension (4 years in our 
data).  
The survey of Baltagi (2008) highlights the existing focus on forecasting in the time dimension. 
In our risk adjustment application, this task is about forecasting the future health costs to 𝜏 periods 
ahead for a given pool of N individuals where their past cost histories over T time periods are 
available. For this forecasting task, Baillie and Baltagi (1999) argue that accounting for individual 
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effects has two potential means of impacting the predictor’s performance: (i) it may lead to better 
estimates of the parameters of the explanatory variables; and (ii) in prediction one may explicitly 
account for the individual effects in constructing the predictor. For (i), FE relies on within individual 
variation. Now, in micro panels, this variation is possibly modest. In addition with small T, the 
estimates of the individual effects are likely to be extremely noisy.  Both effects indicate that the 
preference for FEP over OLSP may be threatened in micro panels.  
With panel data there is a second type of forecast that is possible where the task is to predict 
outside the sample to a new group of 𝑛 individuals for whom there is no past data (e.g., potential 
customers). In our analysis we consider both forms of forecasting, and to distinguish them, we refer 
to forecasting in the cross section dimension as “out-of-sample” forecasting and forecasting in the 
time series dimension as “post-sample” forecasting. In general, both types of forecasting are likely to 
be important and this is especially so in our motivating example of risk adjustment. However, in out-
of-sample forecasting, the FEP will not be operational because there will be no estimated individual 
effects for the new group of 𝑛 individuals. So in this case the comparison is between the OLSP and 
alternative FE based predictors. Following Baillie and Baltagi (1999) we consider a truncated fixed 
effect predictor (TFEP) that utilizes FE estimates of the parameters of the explanatory variables but 
by necessity does not include estimated individual effects in constructing the predictor. In such 
situations, it is natural to consider the role of time invariant explanatory variables which we explore 
using FE predictors based on the Hausman and Taylor (1981) approach.   
There is no shortage of recent research dealing with various aspects of modelling individual 
health care treatment costs and expenditures. Typical key features of health expenditure data that 
make modelling a challenge are the presence of a substantial proportion of zero observations (non-
users of health services) and positive costs that are highly skewed to the right with long thick right-
hand tails. Thus many papers compare alternative modelling approaches tailored to accommodate 
these features using cross sectional data; see for example Jones, Lomas and Rice (2013) who ignore 
the non-users in search for an accurate model of highly skewed data using over 6 million healthcare 
observations.    
What are in relatively short supply are analyses involving panel data. Two recent survey 
papers on econometric modelling in health economics serve to illustrate this divide. Jones (2011) 
surveys the health care cost modelling literature as characterized above but references Jones (2009) 
for discussion of panel data methods. However, there is only a brief mention of health care cost 
modelling for risk adjustment in Jones (2009). Instead the applications focussed on policy evaluation. 
Now the choices made on coverage in these two survey papers could merely be driven by the need 
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to narrow the focus but a close look at the literature does suggest that there has been little work on 
modelling health care costs using panel data.    
Studies where panel have been used to estimate health expenditure models include Seshmani 
and Gray (2004a,b), Stearns and Norton (2004), Albouy et al. (2010) and Hill and Miller (2011).1  In 
estimating the impact of age and time of death on hospital costs, Seshamani and Gray (2004a) find 
that ignoring individual fixed effects results in significant omitted variable bias. Their sample is large 
in both N and T dimensions: over 90,000 individuals with up to 24 years of observations (unbalanced 
panel). However, because the impact of time invariant factors such as sex is of key interest, they rely 
on a random effect model. Seshamani and Gray (2004b) use the same data set but have smaller N 
(9,371) and account for the panel nature of the data only through robust standard errors. Stearns 
and Norton (2004) estimate models using FE but their final predictions of future health costs are 
made based on a random effects specification. Albouy et al. (2010) consider state dependence in 
panel data models. Their sample has moderate size N (about 7,000) and T (up to 6 years). Instead of 
fixed effects, the panel structure is accommodated via Wooldridge (2005) type corrections for initial 
conditions. Hill and Miller (2011) use the US Medical Expenditure Panel Survey (MEPS) data to 
compare the performance of various models of health expenditure. Although the MEPS data is panel 
in nature due to quarterly interviews, the study focuses on annual expenditure so the analysis is 
cross-sectional.   
Thus there is little research that specifically addresses forecasting issues when modelling 
health costs and expenditures using panel data. Before proceeding to an extensive analysis of our 
particular micro panel of healthcare costs, a Monte Carlo study based on Baillie and Baltagi (1999) is 
conducted in order to illustrate the key issues and tradeoffs involved in selecting appropriate 
predictors.  
 
2. Econometric framework 
We abstract from econometric issues that have been the primary subject of many studies 
comparing approaches for modelling health costs such as transforming the dependent variable, 
which invites the problems of re-transformation as policymakers require forecasts in raw scale, and 
accounting for the presence of zero observations. In part, this is to focus attention on issues arising 
                                                          
1 There are also several descriptive studies using commercial MarketScan Databases in the US, which  contains 
data from the employer and health plan sources concerning medical and drug data for several million 
commercially-insured individuals, including employees, their spouses, and dependents collected since 1995 
(e.g. Aizcorbe et al., 2012) and MEPS data (e.g. Zuvekas and Olin, 2009; Bernard et al., 2011).  
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when panel data are available, but it is also a choice supported by past comparisons where simple 
linear models estimated by OLS do relatively well. As Jones (2011) concludes: 
“It is notable that the simple linear model, estimated by OLS, performs quite well across all of the 
criteria, a finding that has been reinforced for larger datasets than the one used here.”  
This is in fact what we have found with preliminary analyses using our data on health expenditures; 
see Ellis et al. (2013). Our expenditure data happen to have a small proportion of zero observations 
due to the setting of a universal public healthcare system. Thus the forecasting comparison here is 
kept narrowly focused on the differences between predictors using estimates produced by OLS and 
by variants using FE estimates in the context of a basic linear panel model with a common set of 
regressors.  
The model is represented by: 
(1)   𝑦𝑖𝑡 = 𝛼 + 𝑥𝑖𝑡
′ 𝛽 + 𝑧𝑖
′𝛾 + 𝜇𝑖 + 𝑣𝑖𝑡; 𝑖 = 1, … , 𝑁, 𝑁 +  1, … , 𝑁 + 𝑛; 𝑡 = 1, … , 𝑇, 𝑇 + 1, … , 𝑇 + 𝜏, 
where there are NT within sample observations and depending on the forecasting task, an extra n 
individuals or an extra  time periods. In using (1) to extrapolate beyond the data used for 
estimation purposes, one could consider producing forecasts for 𝑦𝑖,𝑇+1, … , 𝑦𝑖,𝑇+𝜏. In other words, 
one could forecast future costs for the 𝑖 = 1, … , 𝑁 sample of individuals used for estimation of the 
models parameters; forecasting in the time dimension will be termed post-sample. But it would also 
be relevant to consider a different sample of individuals not used in the estimation stage and predict 
their costs at a given time t; forecasting 𝑦𝑁+1,𝑡, … , 𝑦𝑁+𝑛,𝑡 in the cross sectional dimension will be 
termed out-of-sample. (Obviously there is also the case of post-out-of-sample forecasting,  
𝑦𝑁+𝑛,𝑇+𝜏 ). Several alternative predictors are considered although not all will be available for these 
different forecasting tasks. In this setup the distinction between regressors that vary over both time 
and individuals (𝑥𝑖𝑡) and those that are time invariant (𝑧𝑖) has been made explicit and we have 
allowed for the potential presence of unobservable time-invariant factors, the 𝜇𝑖.  
In their simulation experiments, Baillie and Baltagi (1999) specify the data generating process 
as a classical one-way error component model where the 𝜇𝑖  in (1) are assumed random and 
independent of all regressors. In their comparison of predictors they emphasized the impact of 
accounting for individual effects on both estimation and prediction. But because of their choice of 
data generating process, the resulting estimation problem abstracts from possible biases in 
coefficient estimates and concentrates on relative efficiencies of alternative predictors. While this 
represents a reasonable base case, the alternative situation where the 𝜇𝑖  are potentially correlated 
with the regressors is an important and practically relevant extension. Here the generation of 
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consistent parameter estimates becomes an issue in comparing alternative predictors. The Baillie 
and Baltagi (1999) framework is also extended by considering the out-of-sample forecasting task.  
OLS applied to the pooled data, ignoring the individual specific effects, yields parameter 
estimates denoted by ?̃?, ?̃?, ?̃? and produces the OLS predictor (OLSP) given by: 
OLSP:  ?̃?𝑖𝑡 = ?̃? + 𝑥𝑖𝑡
′ ?̃? + 𝑧𝑖
′?̃?. 
For estimation by FE, the intercept is parameterized to be the mean of the individual specific effects 
implying that the estimated 𝜇𝑖  are restricted to have a zero mean. This provides options in defining 
FE based predictors. If the estimated 𝜇𝑖  are not used in forming forecasts then we call this the 
truncated FE predictor and denote it by TFEP. Alternatively, adding in the estimated fixed effects 
yields the FE predictor denoted by FEP. Thus denoting the FE parameter estimates by  ?̂?, ?̂?, ?̂?𝑖 these 
alternative predictors are defined as: 
TFEP:  ?̂?𝑖𝑡 = ?̂? + 𝑥𝑖𝑡
′ ?̂? 
FEP:  ?̂?𝑖𝑡 = ?̂? + 𝑥𝑖𝑡
′ ?̂? + ?̂?𝑖. 
Consideration of both types of FE predictors is in part motivated by Baillie and Baltagi (1999) who 
distinguished between the impact of accounting for individual effects in parameter estimation and 
then in forming the predictor. Here though it also derives from the feasibility of approaches. In a 
post-sample forecasting task, both of these FE approaches are feasible predictors but only TFEP is 
available in the out-of-sample forecasting task because of the unavailability of estimated 𝜇𝑖  for the 
new sample of n individuals.  
Note that the time-invariant z’s will appear in the OLSP but not in either of the FE predictors. 
From a forecasting perspective this may or may not be an important source of differentiation 
between predictors. In post-sample forecasting, FEP provides a very flexible alternative to allowing 
for the z’s in the predictor. However, in the out-of-sample forecasting task one might expect that 
OLSP potentially has an advantage over TFEP because of the inclusion of the z’s in the predictor.  
In the case of out-of-sample forecasting an additional FE based predictor is defined by 
generating estimates of   from the following regression model: 
(2)   ?̂?𝑖 = 𝜃 + 𝑧𝑖
′𝛾 + 𝜔𝑖  
where the estimated individual specific effects are regressed on the z’s. This estimator is discussed in 
Hsiao (1986) and is a Hausman and Taylor (1981) type estimator that would result under the 
assumption that any correlation between unobservables and regressors is confined to the time-
varying regressors. These two-step estimates denoted by 𝜃, 𝛾 are then used in conjunction with the 
first-step FE estimates to form the Hausman and Taylor predictor HTP:  
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HTP:  ?̂?𝑖𝑡 = ?̂? + 𝑥𝑖𝑡
′ ?̂? + (𝜃 + 𝑧𝑖
′𝛾) 
= (?̂? + 𝜃) + 𝑥𝑖𝑡
′ ?̂? + 𝑧𝑖
′𝛾. 
Using our data we compare the performance of these alternative predictors for both post-
sample and out-of-sample forecasting tasks. In addition, we distinguish concurrent and prospective 
specifications. Equation (1) depicts a concurrent specification where current period’s expenditure is 
explained by current period covariates. Alternatively, the prospective model has next year’s total 
health expenditure as the dependent variable and current period covariates. In practice, the 
prospective specification is preferred for budgeting as it indicates what the health care costs would 
be in the future. However, in terms of model fit, the concurrent specification has a much better fit 
than the prospective specification. By analyzing both models, we therefore can check the sensitivity 
of our results to model fit. Performance is evaluated in terms of forecast mean squared errors (MSE) 
with the ranking based on minimizing MSE (Mean Absolute Prediction Error (MAPE) was also 
calculated but leads to qualitatively the same results). We also compute the predictive ratio which is 
a group-level measure of predictive accuracy. It involves adding up the total predicted expenditure 
for a group of individuals and comparing that value to the actual expenditure for the same group. A 
predictive ratio that is closer to 1 indicates a better fit.  
In the first instance, a Monte Carlo study is conducted in order to illustrate the key issues and 
tradeoffs involved in selecting the appropriate predictor. The Baillie and Baltagi (1999) experimental 
design is used as a base and extensions are restricted to cases where FE approaches, FEP and TFEP, 
produce consistent parameter estimates. Despite this restriction it is not a priori obvious that a FE 
based predictor is necessarily always superior to the OLSP. In Baillie and Baltagi (1999) the often 
substantial superiority of FEP over OLSP derives from the individual heterogeneity in outcomes that 
is accommodated by estimating individual effects. When forecasting out-of-sample, this adjustment 
is not available and hence puts the feasible FE predictor, TFEP, back on a more equal footing with 
the OLSP. Also what is required is a good approximation of the conditional mean function and this is 
not guaranteed by inserting consistent estimates of a subset of parameters, especially when these 
consistent estimators may have large variances because of limited within variation. These arguments 
have prompted the inclusion of a simulation study in order to provide some guidance on what to 
expect when we undertake our extensive empirical analysis. The situation is further complicated 
when time-invariant variables are available and HTPs are considered. This additional issue is not 
addressed in the simulation study but is left to the substantive application that follows as is the 





3. Monte Carlo experiment 
3.1. Simulation design 
The initial data generating process (DGP) to be considered is a variant of (1) where there are no 
time-invariant explanatory variables and a single time-varying covariate implying: 
(3)   𝑦𝑖𝑡 = 𝛼 + 𝑥𝑖𝑡𝛽 + 𝜇𝑖 + 𝑣𝑖𝑡  
where 𝛼 = 5, 𝛽 = 0.5, 𝑣𝑖𝑡~ 𝑖𝑖𝑑 𝑁(0, 𝜎𝑣 
2), and the DGP for 𝑥𝑖𝑡  is given by 
(4)   𝑥𝑖𝑡 = 0.1𝑡 +  0.5𝑥𝑖,𝑡−1 + 𝜀𝑖 + 𝜔𝑖𝑡 
where 𝜔𝑖𝑡 is uniformly distributed on the interval [-0.5, 0.5] and 𝑥𝑖0 = 5 + 10𝜔𝑖0  with the first 20 
observations discarded. The unobserved individual effects are correlated with the explanatory 
variable through the following specification: 
(5)   𝜇𝑖 = 𝜀𝑖 + 𝜂𝑖  
with 𝜀𝑖~ 𝑖𝑖𝑑 𝑁(0, 𝜎𝜀 
2) and 𝜂𝑖~ 𝑖𝑖𝑑 𝑁(0, 𝜎𝜂 
2 ) which implies var(𝜇𝑖) ≡ 𝜎𝜇
2 = 𝜎𝜀
2 + 𝜎𝜂 
2  and 
cov(𝑥𝑖𝑡 , 𝜇𝑖) = 𝜎𝜀
2. This reduces to the Baillie and Baltagi (1999) experimental design when   𝜎𝜀
2 = 0.  
In order to facilitate comparisons, their results are reproduced in what is termed Experiment 1. This 
involves varying 𝜌 = 𝜎𝜇 
2 /(𝜎𝜇
2 + 𝜎𝑣 
2) as 0, 0.3, 0.6 or 0.9 with 𝜎𝜇
2 + 𝜎𝑣 
2   fixed at 20 over 1,000 
replications for each design point. In addition to one-period ahead post-sample forecasts, we also 
provide out-of-sample forecasts for a holdout sample of n=50 individuals. Experiment 2 then repeats 
the analysis adding correlation between the individual effects and the explanatory variable induced 
by setting 𝜎𝜀
2 = 0.81, a value that implies correlations between 0.10 and 0.25. All comparisons are 
done in terms of forecast mean squared errors (MSE). 
  Apart from introducing correlations between unobserved individual effects and the 
explanatory variable, the setup of Baillie and Baltagi (1999) needed to be extended in other respects 
to better reflect the type of applications we seek to explore. In their experiments they set N=50 or 
500 and T=10 or 20 while in Experiments 1 and 2 we specify N=500 or 1,000 and T=3, 10 or 20.  To 
get even closer to a more realistic situation, Experiment 3 is developed based on the actual data to 
be used in our application. Using total health expenditures (𝑒𝑥𝑝𝑖𝑡) as the dependent variable and 
number of standard (less than 20 minutes) visits to a general practitioner (GP) in a year (𝑔𝑝𝑖𝑡)  as 
the sole explanatory variable, a fixed effects specification is estimated for N=1,000 and T=3 and the 
resulting parameter estimates are taken to be the “truth” to generate data for two panel 
configurations (N=500 or 1,000 and T=3). The resulting DGP is given by: 




2 = 46.06  and 𝜎𝑣 
2 = 41.65  and the 𝑔𝑝𝑖𝑡  values are fixed in this “real data” experimental 
design. Note that the estimated individual effects are constrained to sum to zero implying that the 
intercept represents the overall mean of total health expenditures (in thousands). Further details on 
the data will be provided in Section 4. 
 The real data design is completed by specifying a source of omitted variable bias by 
generating the 𝜇𝑖  as follows: 
(7)   𝜇𝑖 = 𝜆𝑠𝑝𝑖 + 𝜂𝑖 
where 𝑠𝑝𝑖  is the mean number of initial specialist consultations in a year for each individual from our 
data normalized to have a unitary variance, again taken to be fixed over replications, and 
𝜂𝑖~ 𝑖𝑖𝑑 𝑁(0, 𝜎𝜂 
2 ). Setting 𝜆 = 0 and varying 𝜌 = 𝜎𝜇 
2 /(𝜎𝜇
2 + 𝜎𝑣 
2)  while keeping fixed 𝜎𝜇
2 + 𝜎𝑣 
2 =
87.71, mimics Experiment 1, but with a very different explanatory variable. Compared to the Baillie 
and Baltagi (1999) design, the contribution to total variation in the dependent variable due to the 
variation in the unobservables is much smaller here as is the within relative to the between variation 
in the single explanatory variable. Because FE estimation relies on the within variation we might 
expect a deterioration in the relative performance of the FEP in this alternative design.  
Setting  𝜆 = 1 reproduces the sample correlation of 0.364 between 𝑠𝑝𝑖 and 𝑔𝑝𝑖𝑡  and 
provides a real data version of Experiment 2. While 𝑠𝑝𝑖  forms part of the DGP, it is taken to be 
unobservable by the researcher and thus is not part of the model specification estimated by OLS and 
FE. Because it is a time-invariant variable, this does not affect the FE estimation but will induce 
parameter biases when OLS is used and 𝜆 ≠ 0.  
 
3.2. Simulation results 
Table 1 provides the MSE results for Experiment 1 when  𝜎𝜀
2 = 0.  The post-sample forecasting 
analysis for N=500 and T=10 or 20 reproduces that part of Table 1 of Baillie and Baltagi (1999) 
corresponding to the predictors of interest here, namely OLSP and FEP. The key feature of this 
subset of the results is that the FEP dominates OLSP except when 𝜌 = 0  and the difference 
increases markedly as 𝜌 increases. Baillie and Baltagi (1999) demonstrate that FEP runs a close 
second to the operational optimal predictor (they term this the “ordinary predictor”) based on the 
true random effects DGP and emphasize the importance of accounting for individual effects in 
estimation and prediction. Further they conclude that the FEP is recommended in practice because 
of this relatively good simulation performance and its robustness to correlation between random 
effects and regressors. Note that they do not extend their experimental design to provide simulation 
evidence in support of the robustness claim.   
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The remaining results in Table 1 provide some initial qualifications to the main findings of 
Baillie and Baltagi (1999). First, the post-sample forecasts when T=3 exhibit a similar pattern except 
there is a relative deterioration in FEP attributable to the reduced within variation in the regressor 
that is associated with the short time dimension. This means that for 𝜌 = 0,  the OLSP dominates 
FEP by a greater margin than when T is larger. The second feature relates to the out-of-sample 
forecasting section of the results where the superiority of a FE approach over OLSP is eliminated.  
Baillie and Baltagi (1999) argue that accounting for individual effects can lead to better estimates of 
the parameters of the explanatory variables and also can provide estimates of the individual effects 
for use in constructing the predictor. In out-of-sample forecasting, TFEP accounts for individual 
effects in estimation but because forecasting relates to a new sample of individuals, there are no 
estimated individual effects and only a single overall mean effect can be used for prediction. The 
result that the performance of the two predictors, TFEP and OLSP, is essentially the same for all N 
and T combinations serves to emphasize that the importance of accounting for individual effects 
relates to their use in prediction rather than estimation.  
Table 1: Post-sample and out-of-sample mean squared errors: Experiment 1 
  Post-sample Out-of-sample  
 
OLSP FEP OLSP TFEP 
N=500, T=10 
    =0 20.045 22.056 20.027 20.027 
 =0.3 20.004 15.450 19.969 19.969 
 =0.6 19.971 8.828 19.924 19.922 
 =0.9 19.947 2.207 19.884 19.882 
N=500, T=20         
=0 19.995 20.994 20.028 20.028 
 =0.3 19.998 14.661 20.061 20.061 
 =0.6 20.001 8.425 19.994 19.994 
 =0.9 20.001 2.097 20.065 20.065 
N=500, T=3         
=0 20.030 26.657 20.064 20.077 
 =0.3 20.012 18.675 20.064 20.067 
 =0.6 20.016 10.671 20.106 20.102 
 =0.9 20.023 2.668 20.108 20.096 
N=1000, T=3         
=0 20.014 26.632 20.151 20.156 
 =0.3 20.034 18.673 20.049 20.052 
 =0.6 20.012 10.670 20.157 20.157 
 =0.9 19.980 2.668 20.285 20.281 
Notes: (i) The first two N, T pairs were chosen to be comparable with the design choices of Baillie and Baltagi (1999) while 
the second two N, T pairs were chosen to be more representative of micro panels.  
(ii) OLSP is the OLS predictor; TFEP is the FE predictor without the estimated individual specific effects; FEP) is the FE 




Table 2 provides the MSE results for Experiment 2 where OLS no longer produces consistent 
parameter estimates because of the non-zero correlation between the explanatory variable and the 
unobserved time-invariant effects. There are no results for 𝜌 = 0 because this implies no 
unobserved time-invariant effects. Setting 𝜎𝜀
2 = 0.81 implies modest levels of correlation (0.10 – 
0.25) between the explanatory variable and the unobserved effects but the biases in the OLS 
parameter estimates are substantial. For example, with 𝑁 = 1,000, 𝑇 = 3 and  𝜌 = 0.9, the mean 
correlation calculated over the 1,000 replications of the experiment was 0.143 while the means of 
the OLS estimates of 𝛼 = 5 and 𝛽 = 0.5  were 1.452 and 1.347, respectively. Despite these large 
parameter biases the pattern in the post-sample MSEs was largely unchanged from Experiment 1: 
the FEP dominates OLSP and the difference increases as 𝜌 increases.  
Table 2: Post-sample and out-of-sample mean squared errors: Experiment 2 
  Post-sample Out-of-sample  
 
OLSP FEP OLSP TFEP 
N=500, T=10 
     =0.3 19.863 15.447 19.514 20.051 
 =0.6 19.762 8.780 19.542 20.074 
 =0.9 19.890 2.205 19.622 20.052 
N=500, T=20         
 =0.3 20.092 14.708 19.714 19.999 
 =0.6 20.121 8.411 19.718 19.984 
 =0.9 20.161 2.094 19.755 20.019 
N=500, T=3         
 =0.3 19.386 18.660 19.471 20.241 
 =0.6 19.471 10.721 19.352 20.175 
 =0.9 19.316 2.670 19.474 20.202 
N=1000, T=3         
 =0.3 19.408 18.667 19.467 20.159 
 =0.6 19.363 10.677 19.435 20.164 
 =0.9 19.414 2.671 19.408 20.034 
Notes: (i) The first two N, T pairs were chosen to be comparable with the design choices of Baillie and Baltagi (1999) while 
the second two N, T pairs were chosen to be more representative of micro panels. 
(ii) OLSP is the OLS predictor; TFEP is the FE predictor without the estimated individual specific effects; FEP is the FE 
predictor with the estimated individual specific effects. 
The pattern in the out-of-sample forecasting section of the results has changed though. In 
Experiment 1 there was essentially no difference between TFEP and OLSP. Now, while the 
differences are modest, OLSP uniformly dominates TFEP despite the fact that OLS produces severely 
biased estimates of the true parameter values. This is an important finding if the models are 
primarily used for out-of-sample forecasting, as in the case of risk adjustment models in health care. 
The out-of-sample superiority of OLSP over TFEP is an artefact of a more general 
phenomenon. Consider a classical linear regression variant of (1) where 𝜇𝑖 = 0 implying that the 
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optimal predictor, in a lowest MSE sense, would require replacing the unknown parameters with 
their OLS estimates. If instead 𝑧𝑖  is not observed, giving rise to a standard omitted variable situation, 
then the “mis-specified” predictor is now only a function of 𝑥𝑖𝑡. Using OLS to estimate the short 
regression produces consistent estimates of population parameters that incorporate the biases due 
to the impact of omitting 𝑧𝑖  and corresponds to the best linear predictor of 𝑦𝑖𝑡  conditional on 𝑥𝑖𝑡 
alone. With panel data, one can obtain consistent estimates of 𝛼 and 𝛽 using a FE estimator but 
using these in the prediction equation that is solely a function of 𝑥𝑖𝑡 means that there is no account 
being taken of 𝑧𝑖  for the purposes of prediction and will produce poor forecasts in the case where 
omitted variable biases occur. It is essentially the same as taking the optimal predictor when both 
𝑥𝑖𝑡 and 𝑧𝑖 are available in (1) but then specifying 𝛾 = 0.    
Table 3: Post-sample and out-of-sample mean squared errors: Experiment 3 
  Post-sample Out-of-sample  
 
OLSP FEP OLSP TFEP 
Uncorrelated 
   N=500, T=3 
    =0 87.465 116.579 88.616 93.835 
 =0.3 87.704 81.527 87.966 93.185 
 =0.6 87.612 46.793 88.023 93.306 
 =0.9 87.200 11.720 87.961 92.745 
N=1000, T=3         
=0 87.696 116.856 88.083 93.327 
 =0.3 87.712 81.908 87.564 92.785 
 =0.6 87.820 46.859 88.384 93.230 
 =0.9 87.733 11.684 87.940 92.957 
Correlated 
   N=500, T=3 
     =0.3 87.253 81.898 87.597 92.102 
 =0.6 87.550 46.775 88.255 92.698 
 =0.9 87.389 11.683 89.578 93.200 
N=1000, T=3         
 =0.3 87.453 81.802 87.591 92.244 
 =0.6 87.365 46.798 87.422 92.088 
 =0.9 87.341 11.669 87.588 92.062 
Notes: (i) Here only the N, T pairs more representative of micro panels are used but results are provided when the 
individual effects are uncorrelated with the explanatory variable (first two panels) and when there is correlation (second 
two panels). 
(ii) OLSP is the OLS predictor; TFEP is the FE predictor without the estimated individual specific effects; FEP is the FE 
predictor with the estimated individual specific effects. 
 
Table 3 provides the MSE results for Experiment 3 where the real data design is utilized. The 
table is partitioned into two parts; the first part mirrors Experiment 1 where the explanatory variable 
is uncorrelated with the unobserved time-invariant effects, and the second part, where such 
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correlation is introduced, mirrors Experiment 2. Qualitatively the overall results are similar. Even 
with a very different explanatory variable, taken from our data, FEP does well in post-sample 
forecasting irrespective of whether OLS parameter estimates are impacted by omitted variable 
biases or not. The situation with out-of-sample results has changed somewhat in that OLSP now 
dominates TFEP in both the uncorrelated and correlated cases. Previously they were almost identical 
in the uncorrelated case but now the within variation is relatively small compared to the between 
variation and this adversely impacts the performance of the TFEP. 
These Monte Carlo results are not meant to represent an exhaustive investigation of issues 
relevant to choice of predictors with micro panel data. Rather they serve to highlight some 
important dimensions of the comparison between alternative predictors that were not evident in 
the work of Baillie and Baltagi (1999), and they provide some indication of what to expect in the case 
study to follow. In particular, we expect the OLSP to perform relatively better in the out-of sample 
forecasting task compared to the post-sample forecasting task. 
 
4. Data 
Our data are derived from the 45 and Up Study of 267,153 New South Wales (NSW) residents 
linked to several administrative data sources of health costs from 2006 to 2009: hospital inpatient 
data and emergency department (ED) data (linked by the NSW Centre for Health Record Linkage 
http://www.cherel.org.au/), Medical Benefits Schedule (MBS) data for medical services such as GP 
and specialist consultations and Pharmaceutical Benefits Scheme (PBS) data of prescription drugs for 
which a government subsidy was paid. The survey was collected only once during this period (45 and 
Up Study Collaborators, 2008), but the health records of the survey respondents are a panel. We 
exclude voluntary participants and those respondents with invalid age (0.1%), and those who died 
during the study period. The final sample is 1,056,096 person-years. The average age of the survey 
respondents is 63 years.  
Individual annual total health expenditure is calculated as the sum of costs of hospital services, 
charges for MBS items and prices of PBS drugs in any given year. The cost of hospital services is 
imputed using the NSW Costs of Care Standards 2009/10 guidelines released by NSW Department of 
Health (NSW Health, 2011). For hospitalization, it varies by diagnostic group, type of treating 
hospital, type of care (e.g., overnight or same day), length of stay, intensive care unit (ICU) hours and 
the use of ventilation machine. For ED presentations, cost varies with hospital type, urgency 
category and whether or not the patient is subsequently admitted. All expenditures are annual and 
indexed to constant 2009AUD$. 
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A common feature of health expenditure data is positive skewness. Figure 1 illustrates that 
while half of the population only use less than $1,700 worth of health care, the top 25% of the 
population use more than $4,200 worth of health care and the very top 5% use in excess of $9,000 
worth of health care. This pattern is consistent across all years, suggesting the absence of any 
relevant structural break in demand within our study period that needs to be accounted for. In the 
last year, however, we observe higher prevalence of very high expenditures, as indicated by longer 
vertical lines at the top scale of $15,000. 
Figure 1: Health expenditure cumulative distribution function by year 
  
Note: y-axis is the cumulative distribution sorted by expenditure. Expenditures above $15,000 are top-coded to make the 
graph for the bulk of observations more visible.  
 
Another typical feature of health expenditure data is a large mass of zero expenditure; the so-
called non-users of health care who may be self-selected. However, our setting is the Australian 
universal public health system which ensures access to health services by all. In our data, less than 
3% of individuals have zero expenditure in any given year. This could also be explained by our older 
sample of individuals, whose demand for health services is relatively higher than the general 
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Time-varying regressors (𝑥𝑖𝑡) are diagnoses during hospitalization and drug groups. To 
summarize this rich information into a manageable number of variables to be put into the regression 
model, we use a US-based risk adjustment tool called DxCG Risk Solutions developed by Verisk 
Health. This is a standard approach in the risk adjustment literature. The software, which extends 
the classification system used by the US Medicare program for paying competing health plans, 
organizes diagnose codes (International Statistical Classification of Diseases version 10) and drug 
codes (Anatomical Therapeutic Chemical Classification) into a large number of non-mutually 
exclusive categories, and imposes hierarchies on diseases and drugs so that more serious or 
expensive conditions take precedence over less serious or expensive conditions. The software also 
performs a number of data-cleaning steps to identify illegal (e.g. coding errors) or invalid (e.g. male 
pregnancies) diagnoses. It has been used by numerous academic papers in the US such as Ash et al. 
(2001), Einav et al. (2013) and Zhao et al. (2005). The result of the grouping is 110 non mutually 
exclusive dummy variables for diagnoses (Related Health Conditions, RCCs) and 123 non mutually 
exclusive dummy variables for drugs (RX groups). Age and its interaction with gender are also 
included as time-varying regressors.  
All other variables from the 45 and Up Survey are time-invariant, some because they are only 
measured at one point in time. To explore the role of various observed individual specific factors in 
explaining variation in health expenditure, we define 3 sets of time-invariant variables. The first set 
z1i consists of basic demographic characteristics, such as sex, marital status, education, the 
possession of a health care concession card, region, foreign born and language status and skin colour 
to capture ethnicity. The second set z2i, augments z1i by including self-reported health variables 
such as self-assessed general health and major chronic illnesses, such as diabetes, hypertension, 
cancers, heart disease, broken bone and asthma. The third set z3i, augments z2i by including 
socioeconomic characteristics, such as income, employment and private health insurance status, and 
lifestyle variables such as smoking, obesity and alcohol consumption. The last set of additional 





5. Forecasting results 
All of the analyses use data drawn from a balanced panel of 264,024 individuals observed for 
four years. For the prospective specification only three years of data are available. These data are 
then divided into estimation and holdout samples that vary depending on the type of forecasting 
analysis being undertaken. Summary statistics of selected variables are provided in the Appendix.  
In the first set of results provided in Table 4 we consider post-sample prediction. Here the 
holdout sample comprises one year of data for all individuals. Predictive MSEs are reported for both 
concurrent and prospective specifications as are comparable within sample measures as a baseline. 
Within sample, and for both concurrent and prospective specifications, the ranking of predictors is 
the same with FEP being better than OLSP which in turn is better than TFEP. What is noteworthy is 
that the superiority of OLSP over TFEP is more pronounced in the prospective specification. What is 
also clear is the superiority of the concurrent specification in terms of fit over the prospective, which 
is not unexpected because the former captures contemporaneous associations.    







Within sample fit  
  OLSP 30.24 76.19 
TFEP 31.04 104.7 
FEP 18.78 40.58 
Prediction, T = 3, =1   
OLSP 48.68 - 
TFEP 49.81 - 
FEP 49.65 - 
Prediction T = 2, =1   
OLSP 30.94 106.1 
TFEP 32.59 158.0 
FEP 33.20 122.2 
Prediction T = 2, =2   
OLSP 49.76 - 
TFEP 51.30 - 
FEP 54.60 - 
Note: N=264,024 in all cases. For within sample fit T=3 for prospective and T=4 for concurrent.  values indicate whether 
the prediction is one or two periods ahead. The covariates of OLSP are the full set of z3, RCC dummies and RX dummies.  
 
Setting aside one or two years of data for post-sample prediction the superiority of FEP 
disappears. In all cases and for both the concurrent and prospective specifications, OLSP produces 
the lowest predictive MSE. For the concurrent specification the differences are relatively small 
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across all three predictors but FEP is not necessarily superior to TFEP. For the prospective case the 
post-sample ordering is clearer with the use of estimated individual fixed effects in FEP improving 
prediction performance relative to TFEP although still remaining inferior to the OLSP.   
Note that unlike the earlier simulation results, the predictive models include both time-
varying and time-invariant predictors. These will remain in the OLSP and one would expect this 
feature to assist predictive performance relative to TFEP. While the time-invariant predictors will 
also be absent from FEP, one expects the use of estimated individual fixed effects which are so 
important in producing a good within sample fit, to compensate. For our application this proves not 
to be the case in the post-sample results presented in Table 4. 
Table 5 provides the analysis of out-of-sample predictions. Here the holdout sample refers a 
randomly selected 20% sample of 52,932 individuals. We also experimented with alternative hold 
out samples and find similar patterns. In terms of both within sample fit and out-of-sample 
predictions and in both concurrent and prospective specifications, it makes no substantive 
difference to the performance of OLSP which z’s are used. Recall that moving from z1 to z3, more 
time-invariant regressors are added but at the same time the exogeneity of these additional 
regressors becomes more problematic. While FEP delivers the best within sample fit, it is not 
feasible for out-of-sample forecasting; individual effects can only be estimated for the 𝑁 individuals 
in the estimation sample. One might then expect the augmentation with the z’s will add significantly 
to performance of FE based predictors, but Table 5 shows that the gain is more modest. Within 
sample fit and out-of-sample predictive performance of HTP changes little with choice of z’s for the 
concurrent specification but does deliver modest improvement in the prospective specification as 
more z’s are added. OLSP is the best performing predictor although the differences are relatively 











Within sample fit  
  OLSP(z1) 29.55 74.92 
OLSP(z2) 29.53 74.36 
OLSP(z3) 29.51 74.20 
TFEP 30.26 102.6 
FEP 18.19 39.19 
HTP (z1) 30.15 96.52 
HTP(z2) 30.11 90.66 
HTP(z3) 30.09 89.85 
Prediction   
OLSP(z1) 33.37 85.23 
OLSP(z2) 33.34 84.68 
OLSP(z3) 33.33 84.54 
TFEP 34.12 113.7 
HTP(z1) 34.02 107.4 
HTP(z2) 33.99 101.5 
HTP(z3) 33.97 100.7 
Notes: (i) In all cases T=3 for the prospective and T=4 for the concurrent specifications. N=211,728 for the within sample fit 
then models are used to predict for a 20% holdout sample of n= 52,932. Because N is different from that used to produce 
Table 4, the comparable within sample MSEs will be different.  
(ii) Three variants of the OLS predictor (OLSP) and the Hausman and Taylor predictor (HTP) are defined depending on which 
of 3 sets of time invariant explanatory variables are used. Moving from z1 to z3, (and hence from OLSP(z1) and HTP(z1) to 
OLSP(z3) and HTP(z3)) more time-invariant regressors are added but at the same time the exogeneity of these additional 
regressors becomes more problematic. 
 
Thus far, the predictive performances have been gauged on the basis of predictive MSEs but 
the relative performance of alternative predictors may very well be sensitive to choice of metric. As 
an alternative, selected comparisons are repeated using the predictive ratio that is commonly used 
in the risk adjustment literature. Unlike predictive MSE that measures model performance at the 
level of the individual, risk ratios measure performance at a group level. For each decile of actual 
expenditure, we calculate the ratio of the aggregate actual expenditure to the aggregate predicted 
expenditure. These ratios are represented in Figures 2 to 4 and predictor superiority is judged by 
how close these ratios are to unity.  
Figure 2 provides a comparison of predictive performance post sample for both concurrent 
and prospective specifications, together with within sample performance as a benchmark. In both 
concurrent and prospective specifications, overestimation of expenditures is the norm, risk ratios 
are almost always less than unity for low risk (expenditure) deciles 1 through 9. The extent of 
overestimation is often extreme and this is more so for the prospective case. Expenditure in the 
highest decile is underestimated and again this is much more pronounced for the prospective 
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specification. The ranking of predictors is stable across specifications. The FEP dominates OLSP both 
within sample and post-sample.     
Figure 2: Predictive risk ratios for post-sample prediction 
 
Turning to the out-of-sample results, the concurrent and prospective specifications are 
provided separately in Figures 3 and 4. Because the choice of time-invariant regressors had limited 
impact on the performance of alternative predictors, all time-invariant regressors are included in 
OLSP and HTP. For both the concurrent and prospective specifications, there is a recurrence of the 
pattern observed in Figure 2, where expenditure in all deciles except the top decile are typically 
overestimated and the expenditures in the largest decile are underestimated. Also, FEP dominates 
within sample but is not operational for out-of-sample forecasts.  
The performance of the feasible concurrent predictors in Figure 3 is very similar, although 
the OLSP does better than either TFEP or HTP for most of the deciles. There is little degradation in 
performance out-of-sample relative to within sample for these predictors but this simply confirms 
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Figure 3: Predictive risk ratios for out-of-sample prediction with concurrent specifications
 
 




































































Figure 4 again highlights the poorer performance of the prospective model relative to that of 
the concurrent specification. Just as in the case of the concurrent specification, the OLSP tends to 
outperform the available alternatives, TFEP and HTP, for most deciles.   
 
6. Discussion  
Overall, the results of the risk adjustment case study point to a clear preference for the OLSP 
over all of the variants of predictors based on FE (FEP, TFEP and HTP) that were considered. There 
were some exceptions where FE based predictors proved superior but these were limited to some of 
the comparisons made on the basis of risk ratios (group-level prediction).  
The superiority of the OLSP for out-of-sample prediction was anticipated from the 
simulation evidence that was presented. For FE based predictors to be competitive they need to 
include estimated individual effects otherwise the possibly better (less biased) estimates of the 
coefficients of the time-varying variables are detrimental to producing good forecasts. In contrast, 
the OLSP will be the best linear predictor conditional on the available regressors. One might 
anticipate that incorporating time-invariant regressors to allow for estimated individual specific 
effects might favourably impact on the relative performance of the FE based predictors. This 
conjecture was considered in our analysis of health expenditures. Using an extensive list of extra 
time-invariant regressors to predict individual specific effects the resultant HTP did indeed provide 
some improvement over the TFEP for use out of sample, but this improvement was not enough to 
overcome the superiority of OLSP. 
Somewhat surprising, given the simulation evidence, was the relative performance of 
predictors in the case of post-sample prediction. Using the estimated individual specific effects in 
time series forecasting did not uniformly improve the forecasting performance of FEP and the OLSP 
was the best performing predictor in all cases when predictive MSE was the performance measure. 
This result proved sensitive to the performance measure and when predictive ratios were used to 
evaluate post-sample performance, the FEP did outperform the OLSP. This was the only situation 
where this ranking occurred.  
The relative performance of the OLSP and FEP in post-sample prediction is impacted by a 
number of factors. In the simulation evidence, FEP did improve monotonically with , the proportion 
of the variability in the unobservables attributable to the individual specific effects. Holding constant 
the signal to noise ratio means the OLSP is unaffected, and so for small enough values of , the OLSP 
is expected to dominate FEP. In our analysis of health expenditures, the estimated values were in 
the range 0.2 to 0.5 depending on the sample and whether the prospective or concurrent 
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specification was used. So while in general this is a possible explanation of the relatively poor 
performance of FEP, these estimates of  suggest this is not the explanation here.  
Instead, two other contributing factors closely associated with micro panel data are likely to 
be the main reasons for the relatively poor performance of FEP. The first of these is the extent of 
within variation, which if limited, as it was in the risk adjustment case study (and likely to be in most 
micro panel data), will result in deterioration in the relative performance of FE based predictors 
through relatively poor estimates of the coefficients of the explanatory variables. The second and 
possibly most important factor that influences the relative performance of predictors is the quality 
of the estimates for the individual specific effects. The dominance of FEP within sample derives from 
the inclusion of the estimated individual effects. But even though non-zero individual effects may 
exist, in cases such as ours with small T available to estimate these effects, they are likely to be 
estimated with considerable variability that contributes to higher predictive forecast variability. The 
consequence is that a simpler model, here OLSP, is likely to prove superior in terms of predictive 
MSE.  
This result, where the simpler OLSP performs well, is consistent with evidence drawn from 
the literature comparing homogeneous and heterogeneous panels; i.e. whether coefficients on 
regressors are allowed to vary over individuals or not. Such comparisons require panels with at least 
modest T values and so are not strictly transferable to the micro panel case. But there is a common 
theme that emerges in this literature that Baltagi (2008) describes as: 
“...while the performance of various estimators and their corresponding forecasts may vary in 
ranking from one empirical example to another, the consistent finding in all studies is that 
homogenous panel data estimators perform well in forecast performance mostly due to their 
simplicity, their parsimonious representation and the stability of parameter estimates.” 
This type of result is highlighted in Clark and McCracken (2012) who formalize the general issue of 
tradeoffs in forecast accuracy associated with noise in parameter estimation.  
The other dimension of the comparisons made, is that between concurrent and prospective 
specifications. The superiority of a concurrent model in terms of lower forecast errors is known. 
Using German data, the MAPE from a prospective model is more than 60% greater than that from 
the concurrent model (Behrend et al. 2007). Using Taiwan data, the corresponding figure is about 
25% (Chang and Weiner, 2010). The results presented here demonstrate similarly large differences 
in performance. This is primarily because the concurrent specification captures more of the costs of 
actual utilization during a year. However, from a post-sample forecasting perspective such a 
specification does not represent a truly operational predictive tool. On the other hand, the 
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prospective specification relies on past factors and so predictions of future utilization are readily 
generated. While the concurrent model more accurately reflects actual spending, for payers using 
risk adjustment models, the prospective model gives advance indication of what their financial 
obligations will be. Thus for payment purposes, the prospective model is used more often than the 
concurrent model; concrete applications include social health insurance in Germany and Medicare 
Shared Savings program in the US. 
To put the concurrent specification on an equal footing with the prospective specification 
requires the use of predicted covariates to make the associated predictors operational. This is not an 
approach implemented here and the question of which of these approaches is better is left for 
further research. What has been emphasized in this paper is the relative performance of alternative 




A rich data set comprising the linkage of a large cohort-representative survey to several 
years of comprehensive health records provides a test bed to explore the relative forecasting 
performance of alternative models of health expenditures. In contrast to much of the risk 
adjustment literature, where such modelling is prevalent, our focus is on predictors that exploit the 
availability of panel data. We also stress the distinction between predictions made out-of-sample 
and post-sample that is possible when panel data are used. While it is unwise to draw strong 
conclusions on the basis of our single case study and a somewhat limited extension of the simulation 
results of Baillie and Baltagi (1999), there are a number of general issues that our work highlights in 
terms of forecasting with micro panels that feature a large number of individuals but limited time 
periods. 
First, the strong preference for FE over OLS estimators when parameter estimation is the 
goal does not readily extend to situations where forecasting is the main task. We demonstrate that 
this preference is fragile, and is likely to be overturned in many practical situations with micro 
panels, including our models of health care costs. Simulation results add support and additional 
insights into the results obtained in the application. These results are supportive of the use of the 
OLSP in a wide range of circumstances.  
Second, while FE based predictors may prove useful in other applications, favourable 
circumstances would need to exist for this to happen. These would include a relatively high 
proportion of the variability in the unobservables attributable to individual specific effects and 
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having regressors with considerable within variation. A third factor that would be helpful is to have a 
relatively large number of time series observations in order to better estimate individual specific 
effects. However, such a situation takes us out of the realm of micro panels into a situation where 
alternative approaches and model specifications might be entertained.     
Despite the limited success of predictors that explicitly utilize the panel structure there are 
advantages of having panel data that have not been highlighted but nonetheless need to be 
recognized. First, the prospective model that arguably is the more useful specification for risk 
adjustment requires panel data. Second, there is likely to be gains in predictive performance that 
derives from simply having extra data. More specifically in the particular case of risk adjustment, the 
key set of predictors is associated with hospital diagnoses, which come sporadically. Panels provide 
richer data in this very important domain.  





45 and Up Study Collaborators. Cohort profile: The 45 and Up Study. International Journal of 
Epidemiology 2008, 37(5): 941-947. 
Aizcorbe A, Liebman E, Pack S, Cutler D, Chernew M, Rosen A. Measuring health care costs of 
individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and 
claims data. Statistical Journal of the IAOS: Journal of the International Association for Official 
Statistics 2012, 28(1): 43-51. 
Albouy V, Davezies L, Debrand T. Health expenditure models: A comparison using panel data. 
Economic Modelling 2010, 27(4): 791-803.  
Ash AS, Zhao Y, Ellis RP, Kramer MS. Finding future high-cost cases: Comparing prior cost versus 
diagnosis-based methods. Health Services Research 2001,26(6) Part II December 194-206. 
Baillie RT, Baltagi BH. Prediction from the regression model with one-way error components. In 
Analysis of panels and limited dependent variable models, Hsiao, C, Lee LF, Pesaran, H (eds.), 
Cambridge University Press, 1999, 225-267. 
Baltagi BH. Forecasting with panel data. Journal of Forecasting 2008, 27(2): 153-173. 
Behrend C, Buchner F, Happich M, Holle R, Reitmeir P, Wasem J. Risk-adjusted capitation payments: 
how well do principal inpatient diagnosis-based models work in the German situation? Results 
from a large data set. European Journal of Health Economics 2007, 8: 31-39. 
Bernard D, Farr S, Fang Z.  National estimates of out-of-pocket health care expenditure burdens 
among nonelderly adults with cancer: 2001 to 2008. Journal of Clinical Oncology 2011, 29: 
2821-2826. 
Chang HY, Weiner J. An in-depth assessment of a diagnosis-based risk adjustment model based on 
national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group 
case-mix system in Taiwan. BMC Med 2010, 8: 7. 
Clark TE, McCracken MW. In-sample test of predictive ability: A new approach. Journal of 
Econometrics 2012, 170: 1-14. 
Einav L, Finkelstein A, Ryan S, Schrimpf P, Cullen M. Selection on moral hazard in health insurance. 
American Economic Review 2013, 103(1): 178–219. 
Ellis RP. Risk adjustment in health care markets: concepts and applications. In Financing Health Care: 
New Ideas for a Changing Society, Lu M and Johnson E (eds.) Wiley, 2008, 177-222. 
Ellis RP, Fiebig DG, Johar M, Jones G, Savage E. Explaining health care expenditure: Large-sample 




Hausman JA, Taylor WE. Panel data and unobservable individual effects. Econometrica 1981, 49(6): 
1377-1398.  
Hsiao C. Analysis of panel data. Cambridge University Press, 1986. 
Hill SC, Miller GE. Health expenditure estimation and functional form: applications of the generalized 
gamma and extended estimating equations models. Health Economics 2011, 19: 608–627. 
Jones A, Lomas J, Rice N. Applying Beta-type size distributions to healthcare cost regressions. 
forthcoming Journal of Applied Econometrics 2013.  
Jones A. Models for health care. in Oxford Handbook of Economic Forecasting , Hendry, D and 
Clements, M (eds.), Oxford, Oxford University Press, 2011, 625-654. 
Jones A. Panel data methods and applications to health economics. in Palgrave Handbook of 
Econometrics Vol 2, Mills TC and Patterson K (eds.), London Palgrave MacMillan, 2009, 557-
631. 
New South Wales Health. Cost of Care Standards 2009/10. New South Wales (AUST): NSW Health; 
2011. 
Seshamani M, Gray J. A longitudinal study of the effects of age and time to death in hospital costs. 
Journal of Health Economics 2004a, 23(2): 217-235. 
Seshmani M, Gray J. Ageing and health-care expenditure: The red herring argument revisited. Health 
Economics 2004b, 13 (4): 303-314.  
Stearns S, Norton E. Time to include time to death? The future of health care expenditure 
predictions. Health Economics 2004, 13(4): 315-327. 
Wooldridge JM. Simple solutions to the initial conditions problem in dynamic nonlinear panel data 
models with unobserved heterogeneity. Journal of Applied Econometrics 2005, 20(1): 39-54. 
Zhao Y, Ash AS, Ellis RP, et al. Predicting pharmacy costs and other medical costs using diagnoses and 
drug claims. Medical Care 2005, 43(1): 34-43. 
Zuvekas S, Olin G. Accuracy of Medicare expenditures in the Medical Expenditure Panel Survey. 











Appendix: Health expenditure data and regressions 
Summary statistics of selected variables 
Variable Mean Variable Mean 
This year expenditure 4.150 Ever diagnosed  
(s.d.) 9.212 High BP 0.356 
Next year expenditure 4.420 Skin cancer 0.285 
(s.d.) 9.807 Breast/prostate cancer 0.058 
Age 62.213 Other cancer 0.062 
(s.d.) 11.150 Heart disease 0.118 
Male 0.463 Stroke 0.031 
Never married 0.062 Diabetes 0.090 
Widowed 0.085 Asthma/fever 0.024 
Separated 0.073 Depression 0.130 
Married* 0.692 Broken bone 0.115 
Divorced  0.028 Urinary leakage 0.351 
Unknown 0.006 Hospitalised Conditions  
Partner 0.054 Infections  0.014 
Foreign language 0.096 Solid tumors 0.014 
Foreign born 0.251 Diabetes II 0.023 
Health card 0.295 Eye conditions  0.026 
Educ: high school* 0.134 Benign/uncertain neoplasms 0.028 
Educ: certificate 0.318 Bladder and urinary conditions 0.023 
Educ: diploma 0.318 Cardiac arrhythmias 0.015 
Educ: university 0.230 Coronary artery disease 0.017 
Major city* 0.450 Gastrointestinal conditions 0.074 
Remote 0.020 Hyperlipidemia and Lipidoses 0.012 
Outer region 0.178 Hypertension 0.037 
Inner region  0.352 Lung diseases 0.012 
SAH: excellent* 0.146 Musculoskeletal condition 0.045 
SAH: very good 0.357 Skin condition 0.013 
SAH: good 0.326 Prescriptions  
SAH: fair 0.115 Angiotensin converting enzyme inhibitors 0.113 
SAH: poor 0.020 Angiotensin ii inhibitors 0.092 
PHI w extra 0.491 Antianginal agents 0.032 
PHI no extra 0.145 Anticoagulants (warfarin) 0.029 
No PHI* 0.365 Antidepressants (non-ssri) 0.060 
LF: other work 0.147 Antidepressants (ssri) 0.052 
LF: full time* 0.339 Antigout agents 0.037 
LF: fully retire 0.374 Antihypertensive combinations 0.084 
LF: disabled 0.042 Anti-infectives (oral) 0.259 
LF: not working 0.099 Antiplatelet agents 0.078 
BMI: underweight 0.013 Asthma, COPD (inhaled beta agonist) 0.097 
BMI: normal* 0.339 Beta-adrenergic blocking agents 0.093 
BMI: overweight 0.366 Calcium channel blocking agents 0.107 
BMI: obese I 0.148 Lipid lowering agents (statin) 0.271 
BMI: obese II 0.042 Nonsteroidal anti-inflammatory agents 0.144 
BMI: obese III 0.017 Oral diabetic agents 0.052 
Current smoker 0.072 Topical steroids/anti-inflammatories 0.094 
Past smoker 0.351 Ulcer/gerd (ppi) 0.212 
Non smoker 0.576 Osteoporosis treatments 0.054 
Note: * reference category. ^ age enters the regression model in 5-year band categories. Also included in the regression 
are year dummies, interaction terms between age categories and sex, dummies for skin colours, income categories, alcohol 
habits, other hospitalised condition dummies (110 in total) and other prescription drugs dummies (121 in total). 
